Magnesium Oxide

CHEMBL1200572 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
40.3 g/mol
LogP
Phase
4

A form of magnesium used as a dietary supplement to prevent magnesium deficiency and as an antacid to relieve heartburn and acid indigestion, also sometimes used to relieve constipation.

Molecular Weight

40.3050 g/mol

TPSA

17.10 Ų

Therapeutic Areas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=[Mg]

InChI

InChI=1S/Mg.O

Molecular Formula

MgO

HBD / HBA

- / 1

Rotatable Bonds

0

Heavy Atoms

2

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

A form of magnesium used as a dietary supplement to prevent magnesium deficiency and as an antacid to relieve heartburn and acid indigestion, also sometimes used to relieve constipation.

Yes, Magnesium Oxide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200572. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 14792. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.